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MANAGING END-OF-LIFE PAIN USING A RECTAL 




Approximately 75% of the terminally ill will experience pain during the 
dying process. Oral opioids are the mainstay of pain management; however, 
patients are often unable to tolerate oral medications at the end of life and 
will need an alternate route of medication administration. Rectal 
administration is an appropriate alternative. End-of-life patients unable to 
tolerate oral pain medications were switched to the rectal route using a rectal 
medication administration device for pain management. Although only four 
patients participated in the pilot project, all patients experienced a decrease 
in pain level. Pain medication administration using a rectal medication 
administration device is a viable alternate route and is low cost, easy to use, 
and effective for dying patients for whom oral medication administration is 
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End-of-life issues, pain management, rectal tube, rectal medication 
administration device, end-of-life symptom management, hospice 
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Managing end-of-life pain using a rectal medication administration 
device 
  
 In 2013, the National Hospice and Palliative Care Organization 
estimated 1.5 to 1.6 million patients had received hospice care1. Ensuring a 
good death is a major challenge for healthcare providers2. Six major 
components of a good death include pain symptom management, clear 
decision making, preparation for death, completion, contributing to others, 
and affirmation of the whole person3. Approximately 75% of terminally ill 
patients will experience pain at the end of life4. Pain is a common symptom 
during the end of life; therefore, pain management is a key element in end-
of-life care. “Good management of physical symptoms allows patients and 
loved ones the space to work out unfinished emotional, psychological, and 
spiritual issues, and thereby, the opportunity to find affirmation at life’s 
end”5(p.1059).  
 
Pain control is a challenging task for end-of-life care, and, 
unfortunately, pain is often untreated or undertreated6. Effective pain 
management may necessitate a variety of control strategies6. Groninger and 
Vijayan emphasized the necessity for strong opioids for effective analgesia 
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in dying patients7. Oral opioids are the preferred method of pain 
management in hospice care8; however, end-of-life patients are often unable 
to tolerate oral routes due to loss of consciousness, inability to swallow, fear 
of aspiration, or too many medications. Warren noted that “persistent 
inability to utilize the oral route is most common when death is imminent”9(p. 
378).  
 
These patients will need an alternate route of medication 
administration, and the rectum provides a viable alternative. The rectal route 
has several benefits including low cost, consistent and predictable absorption 
of medications, ease of use, and good symptom management10. Rectally 
administered medications are as effective or, in some cases, more effective 
than oral medications11. The rectal route has a rapid onset of action, is safe, 
easy, and generally painless, and there is no risk of aspiration. Rectal 
administration also bypasses first pass metabolism and the protein peptide 
drug delivery system12. Almost all oral medications can be given rectally13, 
and oral medications are significantly cheaper than other forms, such as 
sublingual, transdermal, or intravenous.  
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The Local Problem  
Currently, patients unable to tolerate oral medications are switched to 
sublingual or subcutaneous routes (SQ). The transdermal route is not 
considered for pain management in end-of-life patients, due to the long 
period required for sufficient absorption to achieve pain relief. For example, 
Fentanyl patches can provide adequate pain control but take approximately 
12 hours to become effective. Such delays are not acceptable for patients in 
the last hours to days of life6. Similarly, sublingual (SL) medications are not 
always effective in end-of-life patients for a variety of reasons. Some of 
these reasons include inadequate absorption of SL medications in patients 
with extremely dry mucus membranes, inappropriate use of SL medications 
by caregivers, or pocketing of medications in patient’s cheeks, which poses a 
risk for aspiration. Subcutaneous (SQ) medications are effective for end-of-
life pain management; however, supplies and medications for the SQ route 
are expensive. Due to these many factors, a need for an alternative route for 
pain medication management between the oral and SQ routes was identified 
in the hospice setting.  
 
Each patient that is placed on a subcutaneous button is a patient that 
would be eligible for a rectal medication administration device (RMAD). 
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Patients using a subcutaneous button are placed in crisis care, meaning that 
they need daily follow up by a provider and sometimes a bedside nurse for 
symptom management. The number of crisis care patients and the number of 
patients using a subcutaneous button each month was tallied. Over a 3-
month period, the number of patients on crisis care ranged from 42 to 45, 
and the number with a subcutaneous button ranged from 13 to 19. During 
the time period, at least a third of the patients on crisis care were using 
subcutaneous buttons.  
 
Patients unable to tolerate oral medication administration were being 
changed from oral directly to subcutaneous pain medications, the only other 
routes available were sublingual or transdermal routes, and not all 
medications are effective via those routes. Patients often waited a long time 
before subcutaneous medications could be started. Subcutaneous button 
supplies need to be ordered and were often not stocked in case managers’ 
supplies. Subcutaneous medications need to be ordered and picked up or 
delivered from the pharmacy, which could take six hours or longer. These 
patients needed a faster alternative as a possible step between the oral and 
subcutaneous routes.  
 
	  13 	  
 
Purpose 
 The purpose of this evidence-based project was to improve end-of-life 
pain management in hospice patients experiencing uncontrolled pain using a 
rectal medication administration device.  
 
 
Ethical Issues  
 Approval to implement the project was obtained from the 
administration of a large southern California hospice organization. In 
addition, approval to disseminate de-identified data was obtained from the 




 This project was conducted at one of the oldest and largest nonprofit 
hospices in southern California. The organization provides hospice and 
palliative care services to San Diego and south Riverside counties. Each 
patient has a support team that includes hospice-trained physicians and nurse 
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practitioners, nurses trained in pain control and symptom management, 
hospice aides, social workers, spiritual counselors, and volunteers.  
 
 
Practice Change  
 Several activities were involved in implementing the practice change. 
These included formation of a RMAD task force, creation of the RMAD 
device, identifying appropriate medications, developing a standard of 
practice, developing documentation forms, creating training materials, 




Task Force Formation 
 An interdisciplinary task force representing all stakeholders was 
appointed to coordinate the RMAD project. The project was chaired by a 
doctorally prepared nurse practitioner that acted as the project coordinator, 
clinical mentor, and guide. Other members of the task force included 
registered nurses, licensed vocational nurses, social workers, and chaplains. 
Task force members met monthly to keep up to date with the progress of the 
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project and provided feedback for project development. Each task force 
member was given a task to help expedite the project. Examples of tasks 
included creating a RMAD, identifying possible pain medications to be used 
with the device, narrowing participant criteria, and determining possible 
barriers to use of a rectal device.  
 
 
Creating the Device 
The rectal route was determined to be a suitable alternate route and a 
device was put together to help deliver the pain medication. Using the 
company-approved supply vendor, several possible devices were tested and 
a final device approved by the task force. Cost, ease of use, accessibility, and 
reproducibility were all factors in the selection of the final RMAD. The 
RMAD was created with a 16 French Foley catheter, a Luer tip catheter 
adapter, and a 3-way stopcock. The port for the urine collection device was 
removed from the Foley catheter and a Luer tip catheter adapter inserted. 
The 3-way stopcock was then attached to the Luer tip end of the adapter. 
Instructions for creating the device are shown in Figure 1, and the final 
RMAD is depicted in Figure 2.  
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Identifying RMAD medications 
 The RMAD pain medication formulary is based on the current 
emergency kit at the setting. The goal was to be able to use medications that 
were already available in a patient’s home. Each of the medications 
available in the emergency kit, as well as commonly used opioids and other 
pain medications, were thoroughly researched for efficacy and safety of use 
for the rectal route. The head pharmacist at the company-approved pharmacy 




Developing an RMAD standard of practice 
The existing protocol for medication administration via subcutaneous 
button was used as a guideline for developing a standard of practice for the 
RMAD. The standard of practice was reviewed during task force meetings 
and corrections were made and finalized. The RMAD standard of practice is 
the guide for all staff and family members for use of a RMAD. The standard 
of practice describes the purpose of the device and how to contact the 
appropriate staff member for the provider’s order to change the medication 
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route. It also lists what is included in each RMAD kit and provides step-by-
step instructions on how to create the final device from the contents of the 
kit. Detailed instructions for RMAD insertion and removal, medication 
preparation, and medication administration are also included in the standard 
of practice. A list of RMAD medications is also included. 
 
 
Creating Documentation Forms  
A variety of documentation forms and teaching materials were needed 
to implement the project. RMAD forms were created based on the need to 
monitor pain levels. Forms created included a caregiver profile, medication 
form, and the RMAD evaluation form. The caregiver profile elicits 
background information about caregivers that is useful in determining the 
appropriateness of RMAD, such as education level, familiarity with route of 
medication administration, physical limitations and ability to use the 
RMAD, comfort with medication administration, and so on. The medication 
form was developed to monitor types of medication used, amount of water 
used for each administration, and FLACC pain scale before and after 
medication administration using the RMAD. The RMAD evaluation form 
provides feedback on how well managed the patient’s pain is using the 
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RMAD and any questions, concerns, or complications that may arise during 
therapy. All RMAD forms were presented to the site’s clinical operations 
quality team for approval and adoption. Copies of the final version of all 
RMAD forms were branded for site use. 
 
 
Developing Training Materials 
The RMAD training handbook is a one page, front and back, guide 
that provides easy step-by-step instructions at a third grade level for RMAD 
insertion, medication preparation, and medication administration. The 
training handbook was intended to be a quick reference for patients’ 
caregivers and for staff with pertinent RMAD information, such as what a 
RMAD is, RMAD insertion, medication preparation, and medication 
administration via RMAD. The front section provided information about the 
device and what is in each RMAD kit. The second section included how to 
insert the device, how to prepare medications to be used, and how to give the 
prepared medications using the RMAD. Each caregiver was trained using 
this handbook and demonstrated verbal and written understanding of how to 
prepare and give medications using the RMAD. 
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Training RMAD Champions and Triage Staff 
Registered nurse case managers (RNCMs) volunteered to participate 
in the RMAD pilot project. Two nurses from each geographic area served by 
the agency were chosen to be project champions and were trained on the 
RMAD and all forms. Triage staff members, including overnight triage staff, 
were also trained on the RMAD in case they needed to replace the device 
after hours or a patient was admitted that was eligible for RMAD use. 
 
 
Implementing Use of the RMAD 
 Eligibility criteria for patients’ use of an RMAD included admission 
to the hospice’s care, being actively engaged in the dying process (in the last 
hours to days of life), and with an inability to swallow, uncontrolled nausea 
or vomiting, or pain uncontrolled by other routes except the subcutaneous 
route. These patients and their family members were educated about the 
RMAD by a RMAD champion, and, if they agreed to participate, a RMAD 
was inserted. The patient was changed to crisis care status for the first 24 
hours after RMAD placement to monitor pain levels and assure that patients 
and caregivers had adequate support, if needed. Caregivers who were 
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comfortable with management of medications through the RMAD were 
trained to prepare and administer medications and did not need a bedside 
nurse. Caregivers were not trained to insert the device; only the hospice staff 
was allowed to insert the RMAD. Patients were monitored on the RMAD on 
days 1, 2, 3, and 6 after insertion or earlier if complications occurred. 
 
 
Evaluating Project Results 
 The main purpose of this project was to improve pain management 
using a RMAD. The overall goal was a decrease in pain levels for patients 
using RMAD. Specific objectives for this project included: (a) a decrease in 
pain level in 80% of patients, (b) participation of 60% of RMAD eligible 
patients in the program, and (c) participation of 50% of providers in the 
program.  
 
 Evaluation of the effectiveness of this program included whether the 
RMAD was a device that would be accepted by patients, caregivers, and 
staff and the cost-benefit of using a RMAD versus a subcutaneous button. 
Evaluation of the RMAD included review of RMAD packets to evaluate 
pain levels and speaking with caregivers and staff about their opinions of the 
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device and rectal route. The RMAD packets were a folder that included all 
the RMAD forms – caregiver profile, RMAD standard of practice, RMAD 
training handbook, RMAD medication sheet, and RMAD evaluation form. 
Cost analysis for the RMAD compared to the subcutaneous button was 




Objectives a and c were both met. All participating patients 
experienced a decrease in pain levels using a RMAD (see Figure 3) and 
100% of the providers participated in the program. Unfortunately, only 11% 
of RMAD-eligible patients participated in the project (see Figure 4). Some 
reasons for not participating in the program included staff members that 
were not familiar with the device and did not want to use it. Staff members 
unfamiliar with the rectal route also raised doubts in caregivers and often 
talked them out of using the rectal route once they had agreed. Some 
caregivers were adamantly against the rectal route for their loved one, and 
some patients passed before a RMAD champion could get them enrolled in 
the program. 
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A cost comparison for the RMAD versus the subcutaneous button 
showed a savings of $14.34 for the kit and $149.09 for medications. Further 
savings derive from the fact that the subcutaneous button needs to be 
changed every three days and usually there are two buttons placed because 
some medications are caustic and cannot be run through the same device. 
The RMAD does not need to be replaced unless it becomes clogged or is 
removed and even then, the only part that needs to be replaced is the catheter 
itself, at a cost of $0.86. The bulk price for the subcutaneous button kit was 
$17 and the individual pricing for all the components of a RMAD kit totaled 
$2.66. If the RMAD were to be packaged as a self-contained kit, as are the 
subcutaneous button kits, instead of piece-meal ordering, the estimated cost 
per kit at bulk prices would be less than $1. The average cost of medications 
for the subcutaneous button is $180 for methadone, morphine, Ativan, and 
haloperidol. The RMAD only uses medications from the emergency kit at a 




 Continuation of RMAD use would provide an alternate route of 
medication administration that is easy to use, efficient, and cost effective. 
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Every patient experienced a decrease in pain levels, which means that pain 
management was successful using a RMAD. The device is simple to put 
together and also much more portable for RN case managers (RNCMs). 
Using the available emergency medication kit that patients already have in 
their house eliminates the need to wait for medications.  
 
Some limitations of the project included time constraints, patient 
participation, and general attitude towards the rectal route on the part of both 
staff and caregivers. The project was started during first week of December 
2014 and ended in Feb 2015. Patient participation could have been affected 
by RMAD eligibility criteria. In general, staff did not feel that eligibility 
criteria for patient participation in the program were too strict. However, 
there were some concerns about whether the patient needed to meet all 
criteria or a few of the criteria. For this program the main criteria were that 
the patient was actively dying and had pain that could not be managed 
through other methods.  
 
The biggest obstacle to program implementation was overcoming 
negative caregiver and staff attitudes toward using the rectal route. Staff 
attitude was an unexpected barrier. LVNs who were uncomfortable with the 
	  24 	  
device essentially talked the caregivers out of using the rectal device because 
the LVNs would be the ones maintaining the RMAD if the caregivers were 
not comfortable with medication administration via RMAD. Other staff 
simply refused to use a RMAD and were not even open to education about 
the device. Additional champions were needed and trained about halfway 
through the project. A few patients were eligible but because their RNCM 
was not RMAD trained, they needed to contact a RMAD champion, and the 
patients expired by the time a champion could get to the site.  
 
Several lessons were learned as a result of this project, the biggest 
lesson being the need to be adaptable. Many factors came up during the time 
from project initiation to the end. A good environment and site support was 
crucial to implementation of this project. Initiating this project as a pilot 
program was both good and bad. Starting as a pilot meant that the 
availability of the device to the entire site was limited, this was a problem 
because not enough staff was exposed to the device; greater exposure might 
have eliminated the uncertainties some staff had about the device. On the 
other hand, keeping the project small meant that not everyone was trying to 
use the device on every patient, which helped to keep variables low. The 
most useful comment from a RMAD champion was to start talking about the 
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device earlier in the patient’s care so this new and often stigmatized route is 




 Having an additional route for medication administration is vital. 
Although many people are averse to using the rectal route, more education 
needs to be done for medical professionals and caregivers about the ease and 
effectiveness of rectal administration using a RMAD. Using a RMAD 
eliminates the need for caregivers to keep turning their loved ones and to 
constantly be giving rectal suppositories. This creates an increase in patient 
and caregiver satisfaction. Future research can be done using different types 
of medications and/or different populations of patients. More effective 
modes of educating caregivers and staff regarding RMAD use can also be 
studied. 
 
More education of the general population is also needed. The rectal 
route is important not only in end-of-life care, but has the potential to be 
used in other situations, such as a patient with uncontrolled nausea and 
vomiting. This route has the potential to serve many patients.  
	  26 	  
References  
1. National Hospice and Palliative Care Organization. NHPCO facts and 
figures: Hospice care in America. 
http://www.nhpco.org/sites/default/files/public/Statistics_Research/20
14_Facts_Figures.pdf. Published October 2014. Accessed April 20, 
2015. 
 
2. Ellershaw J, Ward C. Care of the dying patient: The last hours or days of 
life. BMJ 2003; 326: 30-34. 
 
3. Steinhauser KE, Clipp EC, McNeilly M, et al. In search of a good death: 
Observations of patients, families, and providers. Ann Intern Med 
2000; 132: 825-832. 
 
4. Fink MJ, Gates RA. Pain Assessment. In: Ferrell BR & Coyle N, eds. 
Oxford Textbook of Palliative Nursing. New York, NY: Oxford 
University Press. 2010: 137-160. 
 
5. Clary PL, Lawson P. Pharmacologic pearls for end-of-life care. Am Fam 
Physician. 2009; 79: 1059-1065.
	  27 	  
 
6. Miller KE, Miller MM, Jolley MR. Challenges in pain management at the 
end of life. Am Fam Physician. 2001; 64: 1227-1235.  
 
7.Groninger H, Vijayan J. Pharmacologic management of pain at the end of 
life.  Am Fam Physician. 2014; 90: 26-32.  
 
8. fraser health. Principles of opioid management. 
https://www.fraserhealth.ca/media/16FHSymptomGuidelinesOpioid.p
df. Published 2006. Accessed April 27, 2015. 
 
9. Warren DF. Practical use of rectal medications in palliative care. J Pain 
Symptom Manage, 1996; 11: 378-387 
 
10. Davis MP, Walsh D, Legrand SB, Naughton M. Symptom control in 
cancer patients: The clinical pharmacology and therapeutic role of 
suppositories and rectal suspensions. Support Cancer Care. 2002; 10: 
117-138. doi: 10.1007/s00520-001-0311-6 
 
	  28 	  
11. Radbruch L, Trottenberg P, Elsner F, Kaasa S, Caraceni A. Systematic 
review of the role of alternative application routes for opioid treatment 
for moderate to severe cancer pain: An EPCRC opioid guidelines 
project. Palliat Med. 2010; 25: 578-596. 
doi:10.1177/0269216310383739  
 
12. Prasanna L, Deepthi B, Rama Rao N. Rectal drug delivery: A promising 
route for enhancing drug absorption. Asian J Res Pharm Sci. 2012; 2: 
143-149.  
 
13. Samala RV, Davis MP. Palliative Care per Rectum: Fast Fact #257. 
Center to Advance Palliative Care. https://www.capc.org/fast-
facts/257-palliative-care-rectum/. Published 2012. Accessed 
September 8, 2013.


















Figure 1. How to Create the RMAD. 1. Unwrap foley catheter. 2. Remove 
plug from urine collection port of the catheter. 3. Insert Luer tip adapter in 
urine collection port of catheter. 4. Make sure Luer tip adapter fits snugly 
into catheter. 5. Attach stopcock to Luer tip adapter. 6. Screw stopcock 
tightly to adapter.
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Figure 2. Final RMAD.  




Figure 3. Pain levels during RMAD intervention. 
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Purpose: The purpose of this project was to improve end-of-life pain 
management among hospice patients using a rectal medication 
administration device (RMAD).  
 
Background: Approximately 1.5 to 1.6 million patients received hospice 
services in 2013 (National Hospice and Palliative Care Organization, 2013), 
and almost 75% of terminally ill patients experience pain during the dying 
process (Fink & Gates, 2010). Patients are often unable to tolerate oral pain 
medications at the end of life. Rectal administration of medication is an 
appropriate alternative for these patients. The rectal route has several 
benefits including low cost, consistent and predictable absorption of 
medications, ease of use, and good symptom management (Davis, Walsh, 
LeGrand, & Naughton, 2002).  
 
Approach: End-of-life patients unable to tolerate oral pain medications are 
currently switched to a subcutaneous button route. These patients will be 
offered the RMAD as an alternative before the subcutaneous button is used. 
After consent is obtained for use, patients will have a trained licensed nurse 
place the device and sit bedside to administer the medications until the 
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patient’s status changes. Pain levels will be monitored before and after 
medication administration using the FLACC scale.  
 
Outcomes: A total of four patients over 3 months, 100% of the patients 
experienced a decrease in pain scores.  
 
Conclusion: This program showed that a RMAD device is useful for pain 
medication administration and resulted in a decrease in pain levels in all four 
participants. Continuation of RMAD use would provide an alternate route of 
medication administration that is easy to use, efficient, and cost effective 
when oral medication administration is not appropriate.   
 
References: 
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138. doi: 10.1007/s00520-001-0311-6 
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Coyle (Eds.), Oxford textbook of palliative nursing (pp. 137-160). New 
York, NY: Oxford University Press. 
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CONCLUSIONS/IMPLICATIONS-FOR-
CLINICAL-PRACTICE-
•  RMAD%would%provide%an%alternate%route%of%medica6on%
administra6on%that%is%easy%to%use,%efficient,%&%cost%effec6ve%
•  Increase%in%pa6ent%sa6sfac6on%
•  Ability%to%use%RMAD%for%other%types%of%medica6ons,%
pa6ents,%&%se@ngs%
•  Patent%for%RMAD%
QUESTIONS?*
COMMENTS?*
